Hydrogen bonding properties of the ω side chain of TXA2 antagonists in the binding domain of the TXA2 receptor.

被引：0
|
作者：
Meier, GP
Taylor, DM
Halushka, PV
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1999年 / 218卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
36-MEDI
引用
收藏
页码：U922 / U922
页数：1
相关论文
共 50 条
  • [31] Antiplatelet Therapy: Targeting the TxA2 Pathway
    P. Fontana
    A. Zufferey
    Y. Daali
    J.-L. Reny
    [J]. Journal of Cardiovascular Translational Research, 2014, 7 : 29 - 38
  • [32] The influence of angiotensin receptors on the TXA2 and NO production
    Tavares, P.
    Pires, L.
    Teixeira, F.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 72 - 72
  • [33] Flavonoids inhibit the platelet TxA2 signalling pathway and antagonize TxA2 receptors (TP) in platelets and smooth muscle cells
    Guerrero, Jose A.
    Navarro-Nunez, Leyre
    Lozano, Maria L.
    Martinez, Constantino
    Vicente, Vicente
    Gibbins, Jonathan M.
    Rivera, Jose
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (02) : 133 - 144
  • [34] PICOTAMIDE INHIBITS TXA2 PLATELET RECEPTORS
    MODESTI, PA
    COLELLA, A
    ABBATE, R
    SERNERI, GGN
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 554 - 554
  • [35] The stable analog carbocyclic TXA2 but not platelet-released TXA2 induces osteoclast-like cell formation
    Gruber, R
    Schöfnagl, M
    Karreth, F
    Fischer, MB
    Watzek, G
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2003, 68 (04): : 267 - 272
  • [36] A PROPOSED COMMON SPATIAL PHARMACOPHORE AND THE CORRESPONDING ACTIVE CONFORMATIONS OF SOME TXA2 RECEPTOR ANTAGONISTS
    JIN, B
    HOPFINGER, AJ
    [J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1994, 34 (04): : 1014 - 1021
  • [37] Modification on ligand binding to TXA2/PGH2 receptors by diethylpyrocarbonate
    Schrör, K
    Davis-Bruno, K
    Halushka, PV
    [J]. EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY 2, PTS A AND B, 1997, 400 : 235 - 240
  • [38] DESENSITIZATION OF TXA2/PGH2 RECEPTOR IN HUMAN-PLATELETS
    MURRAY, R
    CATELLA, F
    FITZGERALD, GA
    [J]. CIRCULATION, 1987, 76 (04) : 483 - 483
  • [39] PURIFICATION AND CHARACTERIZATION OF THE HUMAN PLATELET TXA2/PGH2 RECEPTOR
    NARUMIYA, S
    USHIKUBI, F
    NAKAJIMA, M
    HIRATA, M
    OKUMA, M
    [J]. ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1991, 21 : 339 - 342
  • [40] PHARMACODYNAMICS OF AN INTRAVENOUSLY ADMINISTERED THROMBOXANE (TXA2) RECEPTOR (R) ANTAGONIST
    FRIEDHOFF, LT
    RANIELE, D
    HALSTENSON, CE
    SMITH, SA
    HEDBERG, A
    LIU, E
    SHEPARD, JH
    KEANE, WF
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 123 - 123
12345